Lysophosphatidic Acid Receptor 1 CT (EDG-2)

Lysophosphatidic Acid Receptor 1 CT (EDG-2), N/A

Background: Endothelial cell differentiation gene-2 (EDG2), or LPA1, receptor is a high affinity receptor for lysophosphatidic acid (LPA). EDG2 (LPA1), also known as lysophospholipid receptor A1, Vzg-1, mrec1.3 or GPCR26, like all other EDG receptors, couple multiple (3 or more) types of G proteins and transduce decreases in c[AMP]i through Gi and increases in [Ca2+]i by augmenting phospholipase C through Gq/11 and beta/gamma dimers and by induction of PI3 kinase, p125 FAK, phospholipase D by activating rho through G12/13. Human EDG2 (LPA1) is present in high levels on oligodendrocytes and certain human malignant T cell lines. EDG2 (LPA1) receptors (with EDG4) may play a role in protecting cardiomyocytes from apoptosis induced by hypoxia and andrenergic stimulation.

Concentration: See vial for concentration

Formulation: Provided in solution at 1 mg/ml in phosphate buffered saline.

Caution: This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals.

• Artikelnummer: EXAX1269B
• Hersteller: Exalpha Biologicals Inc
• Hersteller Artikelnummer: X1269B
• Verpackungseinheit: 50 µg
• Mengeneinheit: STK